Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Anticipated Size Of The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Over The Five-Year Period 2025–2029?
The quantitative polymerase chain reaction (qPCR) instruments market has seen substantial growth in recent years. This market is anticipated to increase from $1.51 billion in 2024 to $1.66 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.4%. The expansion observed historically can be linked to the increasing prevalence of chronic diseases, a broader range of applications in genetic and genomic research, rising public and private investments within the life sciences sector, the growing appeal of point-of-care diagnostics, and an escalating demand for high-throughput testing systems.
The quantitative polymerase chain reaction (qPCR) instruments market size is projected to experience rapid expansion over the next few years. It is forecast to grow to $2.45 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.2%. This anticipated growth during the forecast period is largely due to the increasing prevalence of infectious diseases, the rising demand for personalized medicine, the growing utilization of qPCR in oncology, the increasing adoption of qPCR in clinical laboratories, and a heightened focus on early disease detection. Significant trends expected in the forecast period include technological advancements in qPCR platforms, the integration of automation technologies, improvements in microfluidics, the development of multiplex qPCR technologies, and the incorporation of cloud-based data management systems.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25890&type=smp
What Are The Top Growth Drivers Impacting The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Outlook?
The rising occurrence of infectious diseases is anticipated to boost the expansion of the quantitative polymerase chain reaction (qPCR) instruments market. Infectious diseases are conditions caused by detrimental microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly between individuals. The prevalence of these diseases is increasing due to a rise in global travel, which facilitates the swift transmission of pathogens across borders. Quantitative polymerase chain reaction (qPCR) instruments are vital in combating infectious diseases by enabling rapid, sensitive, and precise detection of pathogens, thereby allowing for timely diagnosis and effective disease management. For instance, in February 2024, according to GOV.UK, a UK-based government department, the number of tuberculosis (TB) cases in England escalated from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing incidence of infectious diseases is a key factor propelling the growth of the quantitative polymerase chain reaction (qPCR) instruments market.
What Are The Segment Types Shaping The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?
The quantitative polymerase chain reaction (qpcr) instruments market covered in this report is segmented –
1) By Product Type: Quantitative Polymerase Chain Reaction Systems, Reagents And Consumables, Software
2) By Instrument: 7500, Viia 7 Dx, Cobas 4800, Cfx96, Smartcycler, Genexpert, Rotor-Gene Q, Rotor-Gene Q 5plex Hrm System, Biofire Filmarray Systems, Other Instruments
3) By Application: Gene Expression, Genotyping, Pathogen Detection, Diagnostics, Other Applications
4) By End-Users: Diagnostic Laboratories, Hospitals And Clinics, Pharma And Biotech Companies, Other End-Users
Subsegments:
1) By Quantitative Polymerase Chain Reaction (qPCR) Systems: Real-Time Polymerase Chain Reaction Systems, Portable Or Compact qPCR Devices, Digital Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Master Mixes, Buffers And Enzymes, Primers
3) By Software: Data Analysis Software, Cloud-Based Analytics Platforms, Instrument Control Software
What Key Innovation Trends Are Fueling Advancements In The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?
Leading companies operating within the quantitative polymerase chain reaction (qPCR) instruments market are concentrating on developing innovative solutions, such as next-generation qPCR platforms, to boost testing accuracy, streamline workflow efficiency, and strengthen their competitive position in the diagnostics sector. A next-generation qPCR platform is an advanced molecular diagnostic system designed to deliver superior sensitivity, faster processing, expanded multiplexing, and greater automation for enhanced testing performance and precision. For instance, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced the LightCycler PRO System to provide next-generation qPCR capabilities with improved speed, accuracy, and automation. This system offers reliable, flexible, and efficient real-time PCR results for both clinical and research applications, equipped with advanced multiplexing features, user-friendly software, and precise temperature control for consistent results. Its key benefits include quick adaptation to changing testing demands, optimized workflows with simplified data handling, and an improved user interface featuring a large touchscreen and seamless system integration.
Who Are The Core Companies Influencing The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Landscape?
Major companies operating in the quantitative polymerase chain reaction (qpcr) instruments market are F. Hoffmann-La Roche AG., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf SE, Cepheid Inc., Takara Bio Inc., bioMérieux SA, Analytik Jena GmbH, Standard BioTools Inc., Hangzhou Bioer Technology Co. Ltd., BioTeke Corporation, GeneReach Biotechnology Corp., Anitoa Systems LLC, Blue-Ray Biotech Corp., Chai Biotechnologies, Bio Molecular Systems Pty Ltd., Azure Biosystems Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market During The Forecast Period?
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25890&type=smp
Browse Through More Reports Similar to the Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market 2025, By The Business Research Company
Polymerase Chain Reaction Pcr Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report
Polymerase Chain Reaction Pcr Technologies Global Market Report 2025
Multiplex Pcr Assays Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model